Rockley Photonics completes human study showing promising tracking of objects inside the body versus a standard blood pressure cuff, using its non-invasive, palmless, laser-based device

  • Rockley has successfully demonstrated blood pressure prediction with robust intra-subject tracking using laser-based signaling and without using demographic information

  • Frequent monitoring of blood pressure changes is critical for many applications including health, wellness, fitness, high-demand occupations, and remote patient monitoring.

Oxford, England and Pasadena, California, October 19, 2022– (work wire) – Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), the global leader in photon-based health monitoring and communication solutions, today announced that it has completed an IRB-certified human study of blood pressure measurement that used a palmless gaseous biosensor. , is currently under development.

Based on its innovative laser-based technology, Rockley’s robust blood pressure monitoring technology is not dependent on subject demographics, unlike many current blood pressure monitors.

Continuous, accurate, and comfortable monitoring of blood pressure is expected to promote early diagnosis and treatment of high blood pressure, which is a risk factor for other serious health problems, such as heart disease and stroke. The current standard for measuring blood pressure may not provide the full picture of an individual’s health because it is only measured periodically, usually at a medical appointment. Even daily blood pressure readings taken at home do not capture enough background information because they do not provide frequent and common information or nocturnal changes in blood pressure, which provide better predictors of cardiovascular disease risk.

The data collected in the Rockley Guide to the Study of Understandable Blood Pressure provide promising results. The next phase is a human study with 200 participants, starting this fall. This study will use the next generation of Rockley wearables and will include isometric and aerobic exercise protocols. A direct arterial study with a precise reference pressure-monitoring catheter is also planned for 30 people this fall.

In addition to medical settings, other potential applications of non-surgical sphygmomanometer are clinical trials, athletic and athletic training and workers in occupations that require physical and mental effort such as firefighters and construction workers.

Dr. Andrew Rickman, Chairman and CEO of Rockley, said: “Blood pressure is one of the most important biomarkers and a leading indicator of many serious diseases. This study has shown promising results, and I believe it demonstrates the unique potential of our technology. Our results have been received with a great deal of interest. Excitement from key customers.”

Zahi Fayyad, Ph.D., Professor of Radiology and Medicine (cardiology) and member of the Scientific Advisory Board at Rockley, said: “The preliminary results from this study are exciting because they well follow standard cuff measurements. This technology could potentially fill long-standing gaps in providing improved cardiovascular disease management. bloody.”

The results of the Rockley blood pressure study are presented in a new white paper: Tracking intra-subject blood pressure using innovative laser-based technologyavailable for download at Rockley’s website.

More information about Rockley’s digital health monitoring solution is available here:

About Rockley Photonics

Rockley Photonics, the world leader in photonics-based health monitoring and communication solutions, is a comprehensive portfolio of photonic integrated circuits, modules, sensors and associated integrated solutions. From next-generation sensor platforms designed specifically for mobile health monitoring and machine vision to high-speed, high-volume solutions for data communications, Rockley is laying the groundwork for a new generation of applications across multiple industries. Rockley believes that photonics will eventually become as prevalent as microelectronics, and has developed a platform with the strength and flexibility needed to handle large markets and a wide range of vertical applications.

Founded in 2013, Rockley is uniquely positioned to support large-scale manufacturing and address multiple high-volume markets. Rockley has partnered with many Tier 1 clients across a variety of industries to deliver the complex optical systems required to bring transformative products to market.

To learn more about Rockley, visit

Cautionary note regarding forward-looking statements

Statements in this press release that are not historical facts constitute “forward-looking statements” for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements regarding Rockley’s expectations, beliefs, future plans, goals and assumptions regarding future events or performance. The words “accelerate,” “progress,” “expect,” “believe,” “can,” “ability,” “continue,” “could,” “develop,” “enable,” “estimate,” “ultimately,” “Expand”, “expect”, “focus”, “forward”, “future”, “objective”, “intent”, “may”, “may”, “opportunity”, “expectation”, “planning”, “Possible, or refer to future events, trends or expectations, and expressions similar or negative to such expressions may identify forward-looking statements, but the absence of such words or terms does not mean that the statement is not forward-looking. Forward-looking statements in this press release include, for example: Without limitation, data on: (a) whether continuous monitoring of blood pressure will enhance early diagnosis of hypertension; (b) whether continuous Rockley monitoring of blood pressure will provide better predictors of cardiovascular risk than standard alternatives; (c) the expected timing and standards of the next phase of the study; (d) the potential of our technology; (e) submission of the study results for peer review in an academic publication; (f) the expected features, scope, objectives and benefits the potential of the company’s platform, products and technologies; (g) Rockley’s development of a range of photonic integrated circuits and associated modules, sensors and integrated solutions; (h) Rockley’s belief that photonics will eventually become as prevalent as microelectronics; and (i) Rockley’s ability to support large-scale manufacturing, address multiple high-volume markets, and deliver the complex optical systems required to bring transformative products to market.

Forward-looking statements are subject to many risks, assumptions, and uncertainties (many of which are beyond Rockley’s control) that could cause actual results or performance to differ materially from those expressed or implied by such forward-looking statements. These risks, assumptions, and uncertainties include, but are not limited to, the factors described under “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2021, and in other documents we file with the Securities and Exchange Commission. If any of these risks or uncertainties materialize, or if any of these assumptions prove incorrect, actual results could differ materially from those discussed or implied in these forward-looking statements. There can be no guarantee that future developments affecting Rockley will be those that were foreseen. In view of these risks and uncertainties, you should not place undue reliance on these forward-looking statements. These forward-looking statements speak only as of the date of this document and Rockley does not intend to update or revise any forward-looking statements, whether because of new information, future events or otherwise, except as required by law.

View source version on


The media
Debra Rain
rain makers
Phone number: +1 415-349-7432

Gwen Lauper
Rockley Photonics
Phone: +1 626-995-0001

Leave a Comment